BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors

  April 17, 2026

   · 

  6 min read
• Press Releases

  Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference

  April 17, 2026

   · 

  2 min read
• Press Releases

  BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting

  April 17, 2026

   · 

  10 min read
• Press Releases

  Pulse Biosciences to Host Analyst Event on April 25, 2026

  April 17, 2026

   · 

  1 min read
• Press Releases

  Drug Farm to Present Positive Phase 1b Data for First-in-Class ALPK1 Inhibitor DF-003 in ROSAH Syndrome at IMMUNOLOGY2026™

  April 17, 2026

   · 

  4 min read
• Press Releases

  Byondis to Present Data from its Novel ADC Technology Platforms at the American Society for Cancer Research Meeting 2026

  April 17, 2026

   · 

  4 min read
• 

  Obesity

  Novo may have muscle advantage over Lilly in weight-loss race: preprint

  More patients on Eli Lilly’s tirzepatide lost over 5% of their lean mass versus those on Novo Nordisk’s semaglutide, according to a study that has yet to be peer reviewed.

  April 17, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Government

  RFK Jr. defends Makary, claims pharma ‘owns’ Congress and media

  The pharma industry “own Congress, they own the media,” Health Secretary Robert F. Kennedy, Jr. told lawmakers by way of explaining the bad press against FDA Commissioner Marty Makary following the second rejection of Replimune’s advanced melanoma drug.

  April 17, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome

  April 17, 2026

   · 

  9 min read
• Press Releases

  European Commission Approves Merck’s ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants During Their First RSV Season

  April 17, 2026

   · 

  11 min read